In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin.

Por Jones, R N, Erwin, M E
Publicado em 1992

Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.

Por Jones, R N, Erwin, M E
Publicado em 1992

Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability i...

Por Erwin, M E, Jones, R N
Publicado em 1992

Disk diffusion susceptibility test interpretive criteria for GR69153, a new catechol-substituted cephalosporin.

Por Jones, R N, Erwin, M E
Publicado em 1991

In vitro activity and spectrum of LY333328, a novel glycopeptide derivative.

Por Jones, R N, Barrett, M S, Erwin, M E
Publicado em 1997

Ceftizoxime interpretive criteria for in vitro susceptibility tests with Neisseria gonorrhoeae.

Por Barrett, M S, Jones, R N, Erwin, M E
Publicado em 1993

In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones.

Por Jones, R N, Johnson, D M, Erwin, M E
Publicado em 1996

Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates.

Por Jones, R N, Erwin, M E, Gooding, B B
Publicado em 1992

Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganii.

Por Biedenbach, D J, Jones, R N, Erwin, M E
Publicado em 1993

Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 me...

Por Espinel-Ingroff, A, Pfaller, M, Erwin, M E, Jones, R N
Publicado em 1996

E test as susceptibility test and epidemiologic tool for evaluation of Neisseria meningitidis isolates.

Por Hughes, J H, Biedenbach, D J, Erwin, M E, Jones, R N
Publicado em 1993

Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates.

Por Gooding, B B, Erwin, M E, Barrett, M S, Johnson, D M, Jones, R N
Publicado em 1992

In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin.

Por Erwin, M E, Jones, R N, Barrett, M S, Briggs, B M, Johnson, D M
Publicado em 1991

MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin.

Por Erwin, M E, Jones, R N, Koontz, F P, Gerlach, E H, Murray, P R, Washington, J A
Publicado em 1992

MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP...

Por Bale, M J, Jones, R N, Erwin, M E, Koontz, F P, Gerlach, E H, Murray, P R, Washington, J A
Publicado em 1992

Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.

Por Bale, M J, Jones, R N, Erwin, M E, Koontz, F P, Gerlach, E H, Murray, P R, Washington, J A
Publicado em 1992

In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates.

Por Washington, J A, Jones, R N, Allen, S D, Gerlach, E H, Koontz, F P, Murray, P R, Pfaller, M A, Erwin, M E
Publicado em 1991

Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1.

Por Doern, G V, Jones, R N, Gerlach, E H, Washington, J A, Biedenbach, D J, Brueggemann, A, Erwin, M E, Knapp, C, Raymond, J
Publicado em 1995

Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetan.

Por Jones, R N, Gerlach, E H, Koontz, F P, Murray, P R, Pfaller, M A, Washington, J A, Erwin, M E, Knapp, C C
Publicado em 1991